Legal in the U.S
BPC-157 is a peptide that has attracted significant attention in wellness, recovery, and healthy aging communities
For a substance or method to be added to the List, it must be determined that it meets at least two of the following three criteria: It has the potential to enhance or enhances sport performance It represents an actual or potential health risk to the athletes It violates the spirit of sport The List is released three months ahead of it taking effect so that athletes, their entourage and other stakeholders can acquaint themselves with any modifications
FDA Advisory Panel Votes to Loosen Rules on BPC-157, TB-500, and MOTS-C Despite Agency Scientists' Opposition An FDA advisory committee voted narrowly on July 23, 2026, to recommend that compounding pharmacies gain access to several popular peptide compounds, including BPC-157, KPV, TB-500, and MOTS-C, overriding explicit objections from the FDA's own career scientists and sparking an audible gasp in the meeting room when the tally was announced
a 2025 literature review identified limited clinical evidence, including a retrospective study of 12 patients with knee pain and a Phase I trial in healthy volunteers whose results were not submitted
The main point is that there are proven, science-backed tools for boosting performance and aiding recovery
